These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
582 related items for PubMed ID: 25637857
41. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases. Moczygemba LR, Frei CR, Burgess DS. Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692 [Abstract] [Full Text] [Related]
43. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S. Diagn Microbiol Infect Dis; 2012 Sep; 74(1):62-7. PubMed ID: 22763019 [Abstract] [Full Text] [Related]
48. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M. J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920 [Abstract] [Full Text] [Related]
49. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA. BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861 [Abstract] [Full Text] [Related]
50. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S. Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062 [Abstract] [Full Text] [Related]
51. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY. J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846 [Abstract] [Full Text] [Related]
56. Could traces of fluoroquinolones in food induce ciprofloxacin resistance in Escherichia coli and Klebsiella pneumoniae? An in vivo study in Galleria mellonella with important implications for maximum residue limits in food. Gestels Z, Baranchyk Y, Van den Bossche D, Laumen J, Abdellati S, Britto Xavier B, Manoharan-Basil SS, Kenyon C. Microbiol Spectr; 2024 Jun 04; 12(6):e0359523. PubMed ID: 38687060 [Abstract] [Full Text] [Related]
58. Occurrence and detection of AmpC beta lactamases among clinical isolates of E. coli and K. pneumoniae causing UTI. Rajni E, Rawat U, Malhotra VL, Mehta G. J Commun Dis; 2008 Mar 04; 40(1):21-5. PubMed ID: 19127665 [Abstract] [Full Text] [Related]